Ammana Bio Pharma Ltd. - Research Center
Group () BSE data
Results
Statement
More
Mar ' 06 |
Mar ' 05 |
Mar ' 04 |
Mar ' 03 |
Mar ' 02 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
Secured loans
Unsecured loans
Total
21.23 |
19.30 |
13.82 |
3.81 |
2.10 |
Gross block
18.68 |
16.81 |
11.64 |
0.03 |
0.03 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
18.41 |
16.81 |
11.64 |
0.03 |
0.03 |
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
Miscellaneous expenses not written
Total
21.23 |
19.30 |
13.82 |
3.81 |
2.10 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
90.00 |
90.00 |
30.00 |
10.00 |
10.00 |